Marketresearchdata.net has added a new industry research report on China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022. The report predicts the market size of China In-Vitro Diagnostics (IVD) Market in terms of value USD.
Click below to request sample of the report: https://www.marketresearchdata.net/Reports/make_sample_request/35626
China In-Vitro Diagnostics (IVD) market is likely to more than triple by 2022 from its current level in 2016. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. With an aging population, a rapidly growing middle class and a government encouraging preventive care, China IVD market is slated to show substantial growth in the future. China’s quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future.

This 100 Page report with 34 Figures and 3 Tables has been analyzed from 8 View Points:

1) China IVD Market and Forecast (2007 - 2022)
2) China IVD Segment Wise Market & Forecast (2007 - 2022)
3) Development Environment and Regulatory Status in China IVD market
4) Company Wise IVD Sales & Forecast (2010 - 2022)
5) Registration for In Vitro Diagnostic Reagents in China
6) Regulatory History/Status/Trends in China IVD Market
7) Profiles of Select Private Clinical Labs and Diagnostic Services Companies
8) China IVD Industry Drivers & Challenges

China IVD Market - 8 Application Segments Covered

1. Clinical Chemistry Market
2. Immunoassay Market
3. Hematology Market
4. Coagulation Market
5. Microbiology Market
6. Molecular Testing Market
7. Self Monitoring of Blood Glucose (SMBG) Market
8. Point of Care Testing (POCT) Market

Company Wise IVD Sales & Forecast

1. Roche Diagnostic
2. Abbott Laboratories
3. Sysmex Corporation
4. Mindray Medical International Limited
5. Shanghai Kehua Bio-Engineering Co. Ltd.
6. Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

• Zhejiang Di’an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI-Shenzhen (Privately held)
• OriGene Technologies (Privately held)

Make an enquiry about this report: https://www.marketresearchdata.net/Speak_to_analyst/35626
Key Topics Covered:

1. Executive Summary
2. China IVD Market and Market Share Analysis (2007 - 2022)
3. China IVD - Segments Wise Market and Forecast (2007 - 2022)
4. Development Environment of Chinese IVD Industry
5. Profile of In-vitro Diagnostic Reagents Registration Control
6. Registration for In Vitro Diagnostic Reagents in China
7. China IVD Market - Company Wise Sales Analysis (2010 - 2022)
8. Profiles of Select Private Clinical Labs and Diagnostic Services Companies
9. China IVD Industry Drivers
10. China IVD Industry Challenge
To browse full report visit:
https://www.marketresearchdata.net/category/healthcare/35626-china-in-vitro-diagnostics-ivd-market